- Investing Ideas
- Global Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Global Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
17
High return on equity, past performance and sound balance sheet.
17 companies
Sanofi Consumer Healthcare India
Market Cap: ₹105.5b
Operates as a fast-moving consumer healthcare company in India.
SANOFICONR
₹4,580.30
7D
-2.5%
1Y
-7.3%
ALTEOGEN
Market Cap: ₩19.2t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩359,500.00
7D
-3.6%
1Y
-7.6%
Sanofi India
Market Cap: ₹80.6b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹3,501.40
7D
-0.6%
1Y
-45.6%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹417.2b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,462.75
7D
2.3%
1Y
-13.6%
Abbott India
Market Cap: ₹540.0b
Operates as a pharmaceutical company in India.
500488
₹25,414.45
7D
-2.1%
1Y
-16.5%
Pharma Mar
Market Cap: €1.6b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.
PHM
€94.05
7D
-1.9%
1Y
16.4%
Highnoon Laboratories
Market Cap: PK₨51.1b
Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.
HINOON
PK₨964.97
7D
-6.5%
1Y
3.8%
GlaxoSmithKline Pakistan
Market Cap: PK₨123.3b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨387.15
7D
2.1%
1Y
-15.0%
China Resources Jiangzhong PharmaceuticalLtd
Market Cap: CN¥17.3b
Engages in the manufacture of pharmaceutical products in China.
600750
CN¥27.45
7D
2.4%
1Y
20.1%
Exelixis
Market Cap: US$11.7b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$46.85
7D
5.8%
1Y
27.4%
Consun Pharmaceutical Group
Market Cap: HK$13.3b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$15.83
7D
-3.7%
1Y
62.5%
Rigel Pharmaceuticals
Market Cap: US$596.5m
A biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States.
RIGL
US$30.47
7D
-5.0%
1Y
67.8%
Chugai Pharmaceutical
Market Cap: JP¥14.4t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥8,760.00
7D
1.2%
1Y
6.9%
Gubra
Market Cap: DKK 5.4b
A disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally.
GUBRA
DKK 331.60
7D
-3.8%
1Y
-8.2%
Shandong Wit Dyne HealthLtd
Market Cap: CN¥7.1b
Engages in the pharmaceutical business in China.
000915
CN¥30.17
7D
-3.5%
1Y
-1.7%
Blue Jet Healthcare
Market Cap: ₹72.3b
Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.
BLUEJET
₹416.85
7D
2.1%
1Y
-44.1%
Samsung BiologicsLtd
Market Cap: ₩72.3t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,561,000.00
7D
-2.6%
1Y
-4.8%